Abstract
M1 RNA, the catalytic subunit of Escherichia coli RNase P, forms a secondary structure that includes five sequence variants of the tetraloop motif. Site-directed mutagenesis of the five tetraloops of M1 RNA, and subsequent steady-state kinetic analysis in vitro, with different substrates in the presence and absence of the protein cofactor, reveal that (i) certain mutants exhibit defects that vary in a substrate-dependent manner, and that (ii) the protein cofactor can correct the mutant phenotypes in vitro, a phenomenon that is also substrate dependent. Thermal denaturation curves of tetraloop mutants that exhibit kinetic defects differ from those of wild-type M1 RNA. Although the data collected in vitro underscore the importance of the tetraloop motif to M1 RNA function and structure, three of the five tetraloops we examined in vivo are essential for the function of E. coli RNase P. The kinetic data in vitro are not in total agreement with previous phylogenetic predictions but the data in vivo are, as only mutants in those tetraloops proposed to be involved in tertiary interactions fail to complement in vivo. Therefore, the tetraloop motif is critical for the stabilization of the structure of M1 RNA and essential to RNase P function in the cell.
Keywords: RNase P, M1 RNA, precursor tRNA, precursor 4.5S RNA
Escherichia coli RNase P is a ribonucleoprotein enzyme composed of a single RNA (M1 RNA) and a single protein (C5 protein) subunit. Both subunits are essential for RNase P function in vivo. However, in vitro, M1 RNA alone can catalyze the hydrolysis of all the known RNA substrates of RNase P (1, 2), including precursor tRNAs (ptRNAs) and precursors to 4.5S and 10Sa RNAs (2).
Phylogenetic studies of ribosomal RNA led to the identification of recurring secondary structural motifs such as that of the tetraloop (loops of 4 nts) at the turn of an RNA duplex that has, primarily, one of two sequence variations: GNRA or UNCG (where, N = A, C, G or U; R = A or G) (3). The presence of a tetraloop can confer on short model helices an added thermodynamic stability and therefore one role of a tetraloop might be to stabilize an RNA duplex in a functional RNA molecule (4–6). The tetraloop also could serve to stabilize the tertiary structure of an RNA molecule by making specific contact(s) with a distal site in the molecule (an intramolecular interaction) (7–9). Tetraloops also can form intermolecular interactions, for example, by mediating formation of an RNA-protein complex (10).
M1 RNA has several tetraloops in its proposed secondary structure, as do many other RNAs with identifiable function. Specifically, of the eight loops at the turn of RNA helices in M1 RNA, five are tetraloops (one has the sequence UNCG and four have the sequence GNRA; see Fig. 1). It is not clear what function all the tetraloops of M1 RNA serve or whether they are necessary for RNase P function in vivo. The M1 RNA tetraloops could, in principle, (i) mediate interactions between M1 RNA and the C5 protein, (ii) mediate the binding of M1 RNA to some or all of its RNA substrates, or (iii) stabilize the conformation of M1 RNA through intramolecular interaction. Extensive phylogenetic analysis of RNase P RNA sequences from eubacteria has led to proposals that three (L9, L12, and L14; see Fig. 1) of the five tetraloops are involved in intramolecular interactions (11, 12). Such proposals should be directly relevant to function in vivo, but not necessarily to function in vitro. In this study, the five tetraloops of M1 RNA have been altered to investigate their role in RNase P function. We find that two of the tetraloops are critical for effective processing of two different substrates in vitro, although the effects differ in a substrate-dependent manner. Only mutants of the three tetraloops implicated by phylogenetic analysis in intramolecular interactions display defective phenotypes in vivo.
MATERIALS AND METHODS
Materials.
Restriction endonucleases were purchased from New England Biolabs. DNA oligonucleotides were synthesized (solid phase) at the W. M. Keck Biotechnology Resource Laboratory (Yale Univ.). Vent DNA polymerase was purchased from New England Biolabs. T7 RNA polymerase was purchased from Promega; T7 RNA polymerase for large-scale RNA preparation for thermal denaturation experiments was a gift of W. G. Scott (Univ. of California, Santa Cruz). Nucleoside triphosphates were purchased from Amersham Pharmacia Biotech; DNase I was purchased from Worthington; P-10 (G-25) columns were purchased from Boehringer Mannheim; [α-32P]GTP (400 Ci/mmol) was purchased from Amersham Life Science. Spectra/Por dialysis tubing (molecular weight cut-off of 2,000) was purchased from VWR Scientific.
Mutagenesis and Preparation of RNA.
pJA2′, which harbors the rnpB gene encoding M1 RNA under the control of the phage T7 RNA polymerase promoter, was digested with EcoRI and HindIII to release a fragment with the gene and the upstream promoter. An EcoRI restriction site was introduced in the vector pSelect (Promega) upstream of its phage T7 polymerase promoter. This pSelect construct (digested with EcoRI and HindIII) and the pJA2′ EcoRI/HindIII fragment were ligated. The resultant construct (pSelM1) was used as template for site-directed mutagenesis, according to directions provided by Promega. Oligonucleotide sequences used to generate the nine site-directed mutations in rnpB are available on request. pSelM1, encoding rnpB wild-type or mutation derivatives thereof, was digested with FokI for run-off transcription in vitro to generate full-length E. coli M1 RNA (377 nts). Plasmids encoding the natural E. coli precursors tRNATyr (pTyr) and 4.5S RNA (p4.5S) were linearized with FokI and SmaI, respectively, for run-off transcription in vitro. RNAs then were prepared as described (13). For RNA used in thermal denaturation experiments the transcription reaction was scaled up to 1.0 ml. The RNA then was treated as described (13) with the following differences: the RNA was passed through a P-10 column and after precipitation, was resuspended in 100 μl of distilled H2O and then dialyzed against 200 vol of 6 M urea and 1,000 vol of 1× thermal denaturation buffer (20 mM sodium cacodylate, pH 7.5/400 mM NH4OAc/1 mM MgOAc).
Substrate RNAs were transcribed in the presence of [α-32P]GTP, electrophoresed on a 7 M urea/denaturing polyacrylamide gel, eluted from the gel by incubation in 1× elution buffer [10 mM Tris⋅HCl, pH 7.5/1 mM EDTA/100 mM NaCl/0.01% SDS (wt/vol)] at 37°C for 6–8 hr, and then precipitated.
Assays for RNase P Activity.
Before assay, wild-type or mutant M1 RNA was renatured in 1× buffer A (50 mM Tris⋅HCl, pH 7.5/100 mM NH4Cl/10 mM MgCl2), or, for assays that included C5 protein, in 1× buffer B [10 mM Hepes, pH 7.5/400 mM NH4OAc/10 mM MgOAc/5% (vol/vol) glycerol] by heating the M1 RNA sample at 65°C for 5 min and then allowing it to cool slowly to room temperature (≈2 hr). The activity of wild-type and mutant M1 RNA was measured at 37°C in 1× buffer A supplemented with 90 mM MgCl2. The activity of the holoenzyme (M1 RNA and C5 protein) also was measured at 37°C in 1× buffer B. The wild-type and mutant M1 RNA and substrate were preincubated for 5 min at 37°C, mixed gently, and placed at 37°C. The time points and the M1 RNA concentrations chosen were selected to obtain measurements in the linear portion of the kinetics of the cleavage reaction. Aliquots were taken at specified times, mixed with 1× volume 9 M urea/dye [0.05% (wt/vol) bromophenol blue, 0.05% (wt/vol) xylene cyanol ff] to quench the reaction, vortexed (5 sec), directly loaded and electrophoresed on denaturing polyacrylamide/7 M urea gels (8% wt/vol). The gels were visualized by use of a PhosphorImager (Fuji), and the reactant and product bands were quantified by using a PhosphorImager program (macbas, version 2.0, Fuji). The velocity of the reaction then was estimated from the slope of the curve of substrate cleavage and values for KM and Vmax were determined from Eadie-Hofstee plots.
Subcloning and Complementation in Vivo.
The most proximal natural promoter of rnpB directs nearly all its transcription (14). The plasmid used for complementation studies in vivo was constructed by digesting pNL3100 (which contains the rnpB gene under its natural E. coli promoter and terminator) with EcoRI and SnaBI to generate a single insert. The construct pM1P (rnpB upstream of its natural terminator) was digested with EcoRI/SnaB1, and the vector DNA was isolated. The pNL3100 EcoRI/SnaBI fragment then was cloned into the pM1P EcoRI/SnaBI vector. This generates a construct (hereafter referred to as pComM1) with rnpB under the control of the most proximal natural E. coli rnpB promoter and with a short terminator sequence. The mutant constructs were generated by two rounds of the PCR using the “megaprimer” method (15) (oligonucleotide sequences used to subclone the six site-directed mutations in rnpB are available on request). For complementation, E. coli strain NHY322 (rnpA49), temperature sensitive for RNase P, was transformed with pComM1 constructs. The temperature-sensitive phenotype is complemented by expression of M1 RNA from a high-copy number plasmid (see ref. 16 and references therein). Because NHY322 harbors the tetracycline (Tet) resistance gene and pComM1 harbors the ampicillin (Amp) resistance gene, pComM1 wild-type and mutant constructs were plated on LB Tet/Amp and grown at both 30°C and 43°C for 48 hr. The ability of the mutants to complement rnpA49 was assessed based on the number of colonies on plates.
Thermal Denaturation Measurements.
RNA (≈26 μg) was renatured in 100 μl of 1× thermal denaturation buffer as described above. The volume then was increased to 1.5 ml (final concentration, 0.145 μM) by addition of 1× thermal denaturation buffer. The RNA was placed on ice, and the denaturation curve was measured within 1 hr. Absorbance at 260 nm was monitored as a function of temperature, which was increased at a rate of 1.0°C/min from 5°C to 92°C, in a CARY 13 UV-VIS spectrophotometer equipped with a five-cuvette thermoelectric controller. The wild-type M1 RNA and mutants L14 and L18 were run simultaneously. Three curves were recorded for each RNA, and a mean of these measurements was taken. Thermal denaturation curves then were normalized at 92°C for comparison, and the first derivative was determined to reveal transitions.
RESULTS
Rationale.
Initially, mutants were constructed with the intention to both maintain an added thermodynamic stability that the tetraloop might provide to the RNA helix in which it resides in M1 RNA and to alter the primary sequence and higher-order structure of the tetraloop that might be important for intra- or intermolecular interactions (4–6). Thus, the single UNCG tetraloop (L3) was changed to a GNRA tetraloop and the four GNRA tetraloops (L4, L12, L14, and L18) to UNCG tetraloops (see Table 1). After kinetic characterization of the initial mutants, additional changes were made in certain tetraloops to examine the role of specific residues in the stabilization of the structure of the tetraloop and/or their role in intra- or intermolecular interactions (Table 1). For example, the L9 loop sequence GAAA, was altered to AAAA (L9A111m), a change that removes, a priori, the stability provided by base pairing between G1 and A4 of this tetraloop. Likewise, in L14A212m, the first nucleotide of the sequence GUAA was altered to yield a loop sequence of AUAA. In the mutants L14G214m and L18A316m, the third nucleotide was changed to a G or A, respectively, which, in each case, still might participate in an intra- or intermolecular interaction (see Fig. 1 and Table 1).
Table 1.
Mutant designation | Wild-type sequence (5′ to 3′) [nucleotides] | Mutant sequence (5′ to 3′) |
---|---|---|
L3m | UUCG [39–42] | GAAA |
L9m | GAAA [111–114] | UCCG |
L9A111m | GAAA [111–114] | AAAA |
L12m | GCAA [157–160] | UUCG |
L14m | GUAA [212–215] | UCCG |
L14A212m | GUAA [212–215] | AUAA |
L14G214m | GUAA [212–215] | GUGA |
L18m | GCGA [314–317] | UUCG |
L18A316m | GCGA [314–317] | GCAA |
Changed nucleotides in loop sequence are in bold and italics.
Examination of a three-dimensional model of E. coli M1 RNA indicates that the proposed long-range interactions of tetraloops L9, L14, and L18 are clustered in a region of the RNA on the opposing side of the substrate binding surface (ref. 17; see Fig. 1 A and B), i.e., they participate in forming the foundation of this surface. Guerrier-Takada and Altman (18) demonstrated that M1 RNA catalytic activity can be reconstituted from various fragments or “sequence modules” of its RNA. A subsequent study further delineated two major folding domains of the RNA, referred to here as domains 1 and 2 (ref. 19; see Fig. 1 A and B) that are very similar to the modules mentioned above. Massire et al. (17) proposed that tetraloops L9, L14, and L18 stabilize the interaction between domains 1 and 2 and, thus, the whole structure of M1 RNA (Fig. 1 A and B).
Catalytic Activity of Wild-Type and Mutant M1 RNA as a Function of Mg2+ Concentration.
M1 RNA achieves maximum activity at a Mg2+ concentration of ≈100 mM in 1× buffer A (20). At this Mg2+ concentration tetraloop mutants L3m, L9m, and L12m exhibit wild-type activity (Fig. 2B and Table 2). In contrast, in 100 mM Mg2+, L14m and L18m display, relative to wild type, 33% and <10% activity, respectively (Table 2). However, by increasing the Mg2+ concentration nearly 2-fold (190 mM) the differences in activity of L14m and L18m relative to wild type are lessened to 80% and 48% activity, respectively. Although L9m and L12m reveal no difference in activity relative to wild type at 100 mM Mg2+, there is a small difference at 20 mM Mg2+: the mutants have 66% and 68% activity, respectively. However, mutants that have this level of relative catalytic activity in vitro generally behave as wild type in vivo (21) and so these values of catalytic activity are not considered to be significantly different from wild type. At 20 mM Mg2+, L14m and L18m are not active in vitro under the conditions used (Fig. 2 and Table 2). Both at 20 mM and 100 mM Mg2+, L3m exhibits wild-type activity (Table 2).
Table 2.
[Mg2+], mM
|
||||
---|---|---|---|---|
20 | 37.5 | 100 | 190 | |
WT | 1.0 | 1.0 | 1.0 | 1.0 |
L3m | 0.93 | ND | 1.1 | ND |
L9m | 0.66 | ND | 1.1 | ND |
L12m | 0.68 | ND | 1.2 | ND |
L14m | <0.001 | 0.15 | 0.33 | 0.8 |
L18m | <0.001 | 0.002 | 0.07 | 0.48 |
Wild-type (WT) M1 RNA and L3m, L9m, and L12m were assayed at a concentration of 10 nM; L14m and L18m were assayed at concentrations of 20 nM and 40 nM, respectively. The pTyr concentration was 100 nM. Values are expressed as a fraction of substrate cleaved per min for mutant enzyme divided by substrate cleaved per minute for the WT M1 RNA. ND, not determined.
Enzymatic Activity of Wild-Type and Mutant M1 RNA in Absence and Presence of C5 Protein with pTyr as Substrate.
L14m and L18m, in the absence of C5 protein in 100 mM Mg2+, exhibit the most significant difference in the kinetics of all tetraloop mutants relative to the wild-type M1 RNA (Table 3). L14m shows a 20-fold increase in both KM and kcat whereas L18m shows a 15-fold increase in KM but not a significant difference in kcat, as compared with wild type. The catalytic efficiency (as judged by the value of kcat/KM) of L14m is not significantly different from wild type. In contrast, the catalytic efficiency of L18m is approximately 10-fold less than wild type. The origin of the observed kinetic defect of L14m is not caused only by the identity of the first nucleotide of this tetraloop, as L14A212m does not exhibit as significant a difference in either KM or kcat relative to wild type as does L14m. The third nucleotide of loop L18 does not appear to be the only determinant of the kinetic defect of L18m. However, L18A316m does exhibit changes in both KM and kcat and, therefore, the mutation in third nucleotide in the loop is a contributing factor to the kinetic defects of L18m.
Table 3.
M1 RNA
|
RNase P
|
|||||
---|---|---|---|---|---|---|
KM, nM | kcat, min−1 | kcat/KM, min−1·μM−1 | KM, nM | kcat, min−1 | kcat/KM, min−1·nM−1 | |
WT | 45 ± 9 | 0.1 ± 0.01 | 2.2 ± 0.5 | 44 ± 15 | 25 ± 5 | 0.6 ± 0.2 |
L3m | 36 ± 12 | 0.12 ± 0.01 | 3 ± 1 | 124 ± 22 | 50 ± 8 | 0.4 ± 0.1 |
L9m | 32 ± 20 | 0.17 ± 0.03 | 5 ± 3 | 69 ± 18 | 30 ± 5 | 0.4 ± 0.1 |
L9A111m | 94 ± 59 | 0.29 ± 0.03 | 3 ± 2 | 124 ± 29 | 43 ± 8 | 0.3 ± 0.1 |
L12m | 100 ± 50 | 0.21 ± 0.04 | 2 ± 1 | 109 ± 29 | 33 ± 8 | 0.3 ± 0.1 |
L14m | 844 ± 149 | 2.1 ± 0.4 | 2.5 ± 0.6 | 127 ± 32 | 30 ± 8 | 0.24 ± 0.08 |
L14A212m | 106 ± 27 | 0.7 ± 0.1 | 7 ± 2 | 147 ± 23 | 38 ± 5 | 0.26 ± 0.05 |
L14G214m | ND | ND | ND | 49 ± 11 | 23 ± 3 | 0.5 ± 0.1 |
L18m | 679 ± 120 | 0.15 ± 0.03 | 0.2 ± 0.1 | 38 ± 10 | 9 ± 1 | 0.23 ± 0.07 |
L18A316m | 212 ± 79 | 0.9 ± 0.3 | 4 ± 2 | 10 ± 4 | 6 ± 11 | 0.6 ± 0.1 |
For M1 RNA assays in 100 mM Mg2+, the concentrations of wild-type (WT) M1 RNA, L3m, L9m and L12m were 10 nM, L14m was 20 mM, and L18m was 30 nM; pTyr concentration was in the range of 40 nM to 200 nM (7–9 substrate concentrations). Substrate concentrations greater than 200 nM result in substrate inhibition of WT M1 RNA activity. For RNase P assays in 10 mM Mg2+, M1 RNA WT and mutants at a concentration of 0.4 nM was mixed with a 10-fold excess of C5 protein (4.0 nM), and incubated 5 min at 37°C. The procedure then followed was as that described (see Materials and Methods) with the concentration of pTyr in the range of 10 nM to 1.3 μM (6–9 substrate concentrations). ND, not determined.
The addition of C5 protein to assays performed in 10 mM Mg2+ changes the kinetics of L14m and L18m such that they are not very significantly different from the wild type (Table 3). In the presence of C5 protein in 10 mM Mg2+, as well in its absence in 100 mM Mg2+, the kinetics of the tetraloop mutants L3m, L9m, L9A111m, L12m, and L14G214 are not very different from wild type. L18A316m has a lower KM and kcat relative to wild-type M1 RNA, therefore the ratio of the two parameters (the catalytic efficiency) is about the same as that of the wild type.
Enzymatic Activity of Wild-Type and Mutant M1 RNA in Absence and Presence of C5 Protein, with p4.5S as Substrate.
There are distinct differences in the kinetics of processing of p4.5S from those with pTyr for the tetraloop mutants in both the presence and absence of the C5 protein (Table 4). In the presence of the C5 protein in 10 mM Mg2+, L9m, which has wild-type activity with pTyr as substrate, exhibits a decrease in both KM and kcat relative to wild type with p4.5S as substrate. Under the same conditions with p4.5S as substrate, L18m, as well, has a lower KM and kcat relative to wild type. L14m in the presence of C5 protein exhibits both an increase in KM and kcat, as was observed in the kinetics of the processing of pTyr in the absence of C5 protein (Table 4). The kinetic defects of L14m and L18m also are reflected in initial velocity measurements made in the absence of C5 protein in 100 mM Mg2+ (Table 4). L18m is not active under these conditions. In contrast, L14m is highly active, showing an apparent gain in function in the processing of p4.5S, the opposite of what was found with pTyr as its substrate. L3m, L9m, and L12m exhibit wild-type-like activity.
Table 4.
RNase P
|
||||
---|---|---|---|---|
M1 RNA
|
KM, nM | kcat, min−1 | kcat/KM, min−1·nM−1 | |
Vo | ||||
WT | 1.0 | 375 ± 87 | 63 ± 13 | 0.17 ± 0.05 |
L3m | 0.9 | 431 ± 210 | 33 ± 13 | 0.08 ± 0.05 |
L9m | 1.1 | 98 ± 42 | 13 ± 3 | 0.13 ± 0.03 |
L12m | 0.9 | 273 ± 67 | 35 ± 8 | 0.13 ± 0.01 |
L14m | 2.5 | 2486 ± 550 | 300 ± 88 | 0.12 ± 0.02 |
L18m | <0.1 | 87 ± 32 | 6 ± 1 | 0.07 ± 0.03 |
For M1 RNA assays in 100 mM Mg2+, the concentrations of wild-type (WT) M1 RNA, L3m, L9m, L12m, L14m, and L18m were 0.3 μM; the concentration of p4.5S was 10 μM. Vo, % substrate cleaved/min. For RNase P assays in 10 mM Mg2+, M1 RNA WT and mutants at a concentration of 0.4 nM was mixed with 10-fold excess of C5 protein (4.0 nM), and incubated 5 min at 37°C; the concentration of p4.5S was in the range 15 nM to 3.8 μM (7–9 substrate concentrations).
Complementation in Vivo.
Enzymatic activity assays at 20 mM Mg2+ revealed a small decrease relative to wild type for L9m and L12m (Table 2). A previous study with several mutants of M1 RNA had indicated that a small difference in activity, such as we observe for L9m and L12m, is not predictive of failure to complement in vivo (21). However, we observe that L9m is unable to complement a temperature-sensitive mutant defective in RNase P activity at the nonpermissive temperature (Table 5). This result shows that the results of kinetic studies in vitro do not necessarily reflect functional capability of RNase P in vivo. The G to A change in the L9 tetraloop (L9A111m) complements inefficiently: it does allow the growth of about one-fourth the number of colonies compared with wild-type RNase P at the nonpermissive temperature (43°C; Table 5). L3m and L12m complement in vivo but neither L14m nor L18m do, all in agreement with the results of kinetic studies in vitro (Table 5).
Table 5.
pSelM1 | Complementation |
---|---|
WT | ++++ |
L3m | ++++ |
L9m | − |
L9A111m | + |
L12m | ++++ |
L14m | − |
L18m | − |
The mutants are classified by their ability to complement E. coli NHY322 A49 at 43°C; ++++, indicates complementation of NHY322, A49; +, partial complementation; −, does not complement.
Thermal Denaturation Studies.
Tetraloop mutants L14m and L18m were selected for thermal denaturation studies because of their defects in the processing of both pTyr and p4.5S. Thermal denaturation of wild-type M1 RNA in 1× thermal denaturation buffer that contains either 10 mM or 100 mM Mg2+ does not reveal certain well-defined transitions that are observable in 1 mM Mg2+ (data not shown). Therefore, thermal denaturation curves of wild-type M1 RNA and mutants L14m and L18m were recorded in 1 mM Mg2+. We anticipated that any differences in thermal denaturation would be accentuated at this low Mg2+ concentration because relatively low concentrations of Mg2+ can reveal defects in function in vitro masked at higher concentrations (see Table 2).
It is apparent from the absorbance versus temperature profiles that a difference exists among wild-type M1 RNA and L14m and L18m, as well as between the two mutants themselves (Fig. 3A). The first derivative of the thermal denaturation curve of wild-type M1 RNA exhibits transitions at ≈57°C, ≈77°C, and ≈82°C (Fig. 3B). We note that activity of wild-type M1 RNA reaches a maximum at ≈50–55°C (Fig. 3B Inset), corresponding approximately to a transition at ≈57°C in the curve of first derivatives of the RNAs. The most pronounced differences from wild type in the first derivative of the thermal denaturation curves and the mutants are at ≈77°C and ≈82°C (Fig. 3B).
DISCUSSION
Phylogenetic Predictions.
Phylogenetic studies of eubacterial RNase P RNA sequences have been used to identify covariation of nucleotides distant from each other in sequence space (11, 12). This has led to predictions of long-range interactions involving three of the five tetraloops of E. coli M1 RNA: L9 to base pairs 3/371:4/370 of helix P1; L14 to base pairs 94/108:95/107 of helix P8; and L18 to base pairs 96/106:97-105 of helix P8 (11, 12). The proposed interactions do not all involve standard Watson-Crick base pairing, thereby making it difficult to understand the detailed nature of these long-range interactions. The three long-range interactions are clustered in space in helices P8/P9 of E. coli M1 RNA (see Fig. 1B). The P8/P9 region of E. coli M1 RNA appears to be highly dynamic in structure. It undergoes a change in conformation upon binding of certain substrates and its integrity is important for the function of the enzyme as determined by the phenotypes of mutations in this general region (22–24). It is also of interest that the L14 tetraloop becomes accessible to chemical probing as a consequence of a mutation in helix P7 (G89:C240) (ref. 25, see Fig. 1B). The tertiary interactions in this region of M1 RNA (helices P7-P9), which is at an interface of the two major independent folding domains of the RNA, may be highly cooperative and are undoubtedly complex. For example, examination of the three-dimensional model of M1 RNA shows that the base pair G89/C240 in helix P7 can stabilize the site of interaction in P8 of the L14 tetraloop (ref. 12; see Fig. 1B).
M1 RNA Function in Vitro.
Data from studies of enzyme kinetics, thermal denaturation experiments, and complementation in vivo led us to propose that the L14 and L18 tetraloops have a significant role in determining M1 RNA structure and, consequently, function. The L14 and L18 tetraloop mutants cleave a ptRNA substrate less efficiently than wild-type M1 RNA in a fashion that varies as a function of Mg2+ concentration: the discrepancy with wild-type cleavage ability decreases with increasing concentration of Mg2+ and is accentuated in low concentrations of Mg2+ as one would expect if the tetraloops play a role in stabilizing the structure of M1 RNA. Furthermore, L14m and L18m do exhibit thermal denaturation curves different from wild type, most demonstrably at ≈55°C, ≈77°C, and ≈82°C.
It is apparent from the kinetic data that both the L14 and L18 tetraloops are important for binding of M1 RNA to a ptRNA. The L14 and L18 tetraloop mutants both have increases in KM. Only the L14m has a change in kcat, an increase in the catalytic rate constant. As the rate-limiting step of the reaction of wild-type M1 RNA is product release, an increase in kcat could be indicative of a decrease in the affinity of the enzyme for the product as well, albeit this has not yet been proved for the mutant. However, only the L18 mutant has an overall defect in catalytic efficiency, as a consequence of a structural perturbation that affects ptRNA binding. Consistent with our observations regarding the role of L18, lead ion probing experiments show that the fourth base of the L18 tetraloop is important for maintaining E. coli M1 RNA structure (26). In addition, modifications in this tetraloop and in the proposed site of its intramolecular interaction (the P8 helix) disrupt tRNA binding (26).
The L14 and L18 tetraloop mutants have totally different effects with p4.5S as substrate as compared with those with pTyr as substrate. L14m with p4.5S as substrate in the presence of C5 protein exhibits the same changes in KM and kcat as it does with a ptRNA as substrate. However, similar changes are observed for the ptRNA substrate in the absence of C5 protein. C5 protein cannot compensate for the effect of this tetraloop mutation on the kinetic parameters of M1 RNA with p4.5S. L18m also differs in the kinetics of cleavage with p4.5S as compared with pTyr in the presence of C5 protein (Table 4). With L18m, there is a decrease in KM and a decrease in kcat in the processing of p4.5S. The L18m holoenzyme forms a “tighter” complex with p4.5S than does wild-type RNase P.
M1 RNA, lacking nucleotides 94–204, is unable to catalyze the hydrolysis of pTyr but it does cleave p4.5S when it is part of the holoenzyme complex (19). Obviously, nucleotides 94–204 are part of a domain of M1 RNA that is critical in the processing of ptRNA. All the tertiary interactions discussed above are disrupted in the large deletion mutant. However, disruption of the putative interaction of L14 with P8 alone, an interaction that, a priori, is important for stabilizing the domain encompassing nucleotides 94–204, increases the observed rate of processing of p4.5S but decreases the rate of processing of the ptRNA. These data, together, appear to suggest that disrupting the presumptive “L14/P8” interaction or the connection of domain 1 with domain 2 alters the structure of M1 RNA in a way that enables the enzyme to enhance cleavage of a p4.5S-like substrate, as determined previously (18).
Holoenzyme Function in Vitro and in Vivo.
A significant test of the importance of a given structural motif in M1 RNA would be to assess its necessity for the function of the enzyme both in vivo and in vitro. The comparison also would be a test of the validity of predictions based on phylogenetic analysis. Phenotypes of mutations, including tetraloop mutations, in M1 RNA that have a deleterious effect on its activity can be “overcome” by C5 protein in vitro (21). The kinetic data for M1 RNA alone in vitro do suggest that the L14 and L18 tetraloops are important for function of M1 RNA and the implications for these mutants in vivo are confirmed by complementation tests. The L3, L9, and L12 mutants show no significant diminishment of function in vitro. However, L9m cannot complement a strain thermosensitive in RNase P function in vivo. Therefore, there is a discordance in this case between function in vitro and in vivo. The mutants (L9m, L14m, and L18m) that exhibit defects in vivo are exactly those predicted by phylogenetic analysis to be involved in tertiary interactions (11, 12).
Acknowledgments
We are grateful to Dr. D.M. Crothers and J. Carruthers for guidance with the thermal denaturation experiments. D.A.P.K. thanks Dr. E. Westhof for encouragement and advice. We thank members of our lab, in particular Drs. V. Gopalan and C. Guerrier-Takada for advice. We also thank Dr. B. Schmid for assistance with figures. Research in S.A.’s laboratory is supported by U.S. Public Health Service Grant GM-19422 and Human Frontier Science Program Grant RG0291. D.A.P.K. acknowledges the support of a National Institutes of Health predoctoral training grant to Yale University.
ABBREVIATIONS
- ptRNA
precursor tRNA
- p4.5S
precursor 4.5S RNA
References
- 1.Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. Cell. 1983;35:849–857. doi: 10.1016/0092-8674(83)90117-4. [DOI] [PubMed] [Google Scholar]
- 2.Altman S, Kirsebom L. In: The RNA World. Gesteland R F, Cech T R, Atkins J P, editors. Plainview, NY: Cold Spring Harbor Lab. Press; 1999. pp. 351–380. [Google Scholar]
- 3.Woese C R, Winker S, Gutell R R. Proc Natl Acad Sci USA. 1990;87:8467–8471. doi: 10.1073/pnas.87.21.8467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.d’Aubenton-Carafa Y, Uhlenbeck O C, Tinoco I., Jr Proc Natl Acad Sci USA. 1988;85:1364–1368. doi: 10.1073/pnas.85.5.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cheong C, Varani G, Tinoco I., Jr Nature (London) 1990;346:680–682. doi: 10.1038/346680a0. [DOI] [PubMed] [Google Scholar]
- 6.Heus H A, Pardi A. Science. 1991;253:191–194. doi: 10.1126/science.1712983. [DOI] [PubMed] [Google Scholar]
- 7.Jaeger L, Michel F, Westhof E. J Mol Biol. 1994;236:1271–1276. doi: 10.1016/0022-2836(94)90055-8. [DOI] [PubMed] [Google Scholar]
- 8.Murphy F L, Cech T R. J Mol Biol. 1994;236:49–63. doi: 10.1006/jmbi.1994.1117. [DOI] [PubMed] [Google Scholar]
- 9.Cate J H, Gooding A R, Podell E, Zhou K, Golden B L, Kundrot C E, Cech T R, Doudna J A. Science. 1996;273:1678–1685. doi: 10.1126/science.273.5282.1678. [DOI] [PubMed] [Google Scholar]
- 10.Gluck A, Endo Y, Wool I G. J Mol Biol. 1992;226:411–424. doi: 10.1016/0022-2836(92)90956-k. [DOI] [PubMed] [Google Scholar]
- 11.Brown J W, Nolan J M, Haas E S, Rubio M A T, Major F, Pace N R. Proc Natl Acad Sci USA. 1996;91:3001–3006. doi: 10.1073/pnas.93.7.3001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Massire C, Jaeger L, Westhof E. RNA. 1997;3:553–556. [PMC free article] [PubMed] [Google Scholar]
- 13.Gopalan V, Baxevanis A D, Landsman D, Altman S. J Mol Biol. 1997;267:818–829. doi: 10.1006/jmbi.1997.0906. [DOI] [PubMed] [Google Scholar]
- 14.Lee Y, Ramamoorthy R, Park C-U, Schmidt F J. J Biol Chem. 1989;264:5098–5103. [PubMed] [Google Scholar]
- 15.Sarkar G, Sommer S S. BioTechniques. 1990;8:404–407. [PubMed] [Google Scholar]
- 16.Kirsebom L A, Baer M F, Altman S. J Mol Biol. 1988;204:879–888. doi: 10.1016/0022-2836(88)90048-4. [DOI] [PubMed] [Google Scholar]
- 17.Massire C, Jaeger L, Westhof E. J Mol Biol. 1998;279:773–779. doi: 10.1006/jmbi.1998.1797. [DOI] [PubMed] [Google Scholar]
- 18.Guerrier-Takada C, Altman S. Proc Natl Acad Sci USA. 1992;89:1266–1270. doi: 10.1073/pnas.89.4.1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Loria A, Pan T. RNA. 1996;2:551–563. [PMC free article] [PubMed] [Google Scholar]
- 20.Guerrier-Takada C, Haydock K, Allen L, Altman S. Biochemistry. 1986;25:1509–1515. doi: 10.1021/bi00355a006. [DOI] [PubMed] [Google Scholar]
- 21.Lumelsky N, Altman S. J Mol Biol. 1988;202:443–454. doi: 10.1016/0022-2836(88)90277-x. [DOI] [PubMed] [Google Scholar]
- 22.Guerrier-Takada C, Lumelsky N, Altman S. Science. 1989;246:1578–1584. doi: 10.1126/science.2480641. [DOI] [PubMed] [Google Scholar]
- 23.Knap A K, Wesolowski D, Altman S. Biochimie. 1990;72:779–790. doi: 10.1016/0300-9084(90)90187-l. [DOI] [PubMed] [Google Scholar]
- 24.Pomeranz Krummel D A, Altman S. RNA. 1999;5:1021–1033. doi: 10.1017/s1355838299990416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shiraishi H, Shimura Y. EMBO J. 1989;7:3817–3821. doi: 10.1002/j.1460-2075.1988.tb03266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Heide C, Pfeiffer T, Nolan J M, Hartmann R K. RNA. 1999;5:102–116. doi: 10.1017/s1355838299981499. [DOI] [PMC free article] [PubMed] [Google Scholar]